Alan Robert Ross | TalkMarkets | Page 1
Contributor's Links: Trust Intelligence
I started trading cheap mining stocks as a Graduate Student in the Neureopsychology Lab of McGill's Allan Memorial Institute before the term "daytrading" was invented. In my spare time, I read everything on investing in the Business School library and I devoured their collection of ...more


Latest Posts
1 to 3 of 3 Posts
Omeros Derisked
Omeros has recently reported progress that derisks the company. The fundamental risk reduction has not been reflected in the excessively discounted share price.
Omeros' Path To OMS7211 Approval
OMS721 just was awarded FDA Breakthrough Therapy Designation for yet another disorder; to treat patients at significant risk of dying after Hematopoietic Stem Cell Transplant.
Provectus Phase III Melanoma Trial Results Earlier Than Planned?
Based upon pre-existing and clear data on safety & efficacy, it is very likely that the PVCT Phase III pivotal melanoma trial will demonstrate the safety and efficacy of PV-10 to the market and to prospective acquirers earlier than anticipated.
1 to 3 of 3 Posts